Soleno Therapeutics, Inc. - Common Stock (SLNO)
46.46
+0.75 (1.64%)
Soleno Therapeutics Inc is a biopharmaceutical company focused on developing innovative therapies for rare diseases, particularly those associated with genetic and metabolic disorders
The company is committed to addressing significant unmet medical needs by advancing its proprietary treatment candidates through clinical trials. With an emphasis on leveraging cutting-edge science and research, Soleno aims to bring novel solutions to patients suffering from conditions like Prader-Willi syndrome, thereby enhancing their quality of life and overall health outcomes.
Previous Close | 45.71 |
---|---|
Open | 45.72 |
Bid | 45.38 |
Ask | 46.60 |
Day's Range | 45.37 - 46.69 |
52 Week Range | 36.20 - 60.92 |
Volume | 565,825 |
Market Cap | 379.52M |
PE Ratio (TTM) | -17.21 |
EPS (TTM) | -2.7 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 569,881 |
News & Press Releases
Why Soleno Therapeutics Stock Blasted 9% Higher Todayfool.com
The company's Prader-Willi treatment inched closer to FDA approval.
Via The Motley Fool · October 8, 2024
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · October 8, 2024
Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · August 27, 2024
SLNO Stock Earnings: Soleno Therapeutics Beats EPS for Q2 2024investorplace.com
SLNO stock results show that Soleno Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 7, 2024
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmakerbenzinga.com
NVIDIA Corp. (NASDAQNVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance ranking.
Via Benzinga · May 29, 2024
Why Soleno Therapeutics Stock Is Skyrocketing Todayfool.com
The clinical-stage biotech company received great news from the FDA.
Via The Motley Fool · April 29, 2024
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/22
Soleno Therapeutics, Inc. (NASDAQSLNO) is the focus of IBN’s latest stock spotlight. The company’s shares have moved -1.14% on the day to $48.05.
Via Investor Brand Network · February 22, 2024
SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q1 2024investorplace.com
SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 9, 2024
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?benzinga.com
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc. (NASDAQAMZN) on Tuesday and Apple Inc.
Via Benzinga · April 29, 2024
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Via Benzinga · April 29, 2024
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · April 29, 2024
SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023investorplace.com
SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 6, 2024
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/20
Soleno Therapeutics, Inc. (NASDAQSLNO) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 2.83% on the day to $48.66.
Via Investor Brand Network · February 20, 2024
Soleno Therapeutics Inc. (NASDAQ: SLNO) Climbs to New 52-Week High
Shares of Soleno Therapeutics, Inc. (NASDAQSLNO) traded at a new 52-week high today and are currently trading at $23.03. So far today, approximately 140.58k shares have been exchanged, as compared to an average 30-day volume of 383.77k shares.
Via Investor Brand Network · January 9, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · January 29, 2024
Forget The Magnificent 7: Did Anyone Back These 1,000% Gainers In 2023?benzinga.com
Baron Fifth Avenue Growth Fund gained nearly 60% over the year, while the Fidelity Blue Chip Growth ETF climbed 59%.
Via Benzinga · December 28, 2023
These Two Companies Surpass Nvidia, Apple And Microsoft with Astounding 1000% Returns In 2023benzinga.com
The two companies outperformed the 'Magnificent Seven' group of stocks, which includes tech giants such as Nvidia, Apple, and Microsoft.
Via Benzinga · December 28, 2023
Why Soleno Therapeutics Stock Ticked Higher on Thursdayfool.com
The latest pundit take on the stock provided a good reason for bulls to snap it up.
Via The Motley Fool · December 21, 2023
Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023investorplace.com
These three stocks to take profits on rallied more than 200% this year. Those gains are exceedingly unlikely to repeat in 2024.
Via InvestorPlace · December 14, 2023
3 Stock Winners That Are Up 500% or More in 2023investorplace.com
If you want to find 2023's top-performing stock, check out these companies that returned 500% or more since January
Via InvestorPlace · December 14, 2023
7 Stock Winners That Are Up 1,000% or More in 2023investorplace.com
Could any or all of these seven stocks up 1000% this year go on another hot run during 2024? Let's find out.
Via InvestorPlace · December 12, 2023
5 ‘Jackpot’ Stocks to Buy for 2024 for 10X Gainsinvestorplace.com
These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent.
Via InvestorPlace · December 4, 2023
Feeling Lucky? 5 ‘Jackpot’ Stocks to Buy for 2024.investorplace.com
When investors land on a "jackpot" stock, gains can offset even the steepest losses. Here are the top stocks to buy if you're feeling lucky.
Via InvestorPlace · November 27, 2023